Clinical trial NCT03676920: Feasibility and Utilization of an Application-based Question Prompt List
Official title: Improving Treatment Cost Discussions Between Cancer Patients and Their Oncologists: Feasibility and Utilization of an Application-based Question Prompt List
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Financial Toxicity
Cancer
Question Prompt List
Keywords: cancer treatment cost, patient-provider communication
Lead sponsor: Barbara Ann Karmanos Cancer Institute
Sponsor class: OTHER
First posted: 2018-09-19
Enrollment: 35
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: The research tests the feasibility of an application-based ("app") communication intervention designed to improve the frequency and quality of patient-oncologist treatment cost discussions during clinical interactions, and associated measures.
Primary purpose: OTHER

Brief summary: This trial studies how well an application-based question prompt list works in improving treatment cost discussion between patients with breast, prostate, lung, or colorectal cancer and their oncologists. An application-based question prompt list, called Discussion of Cost Application (DISCO App), may help to improve how patients and oncologists discuss cancer treatment costs.

Detailed description: The overall goal of this research is to reduce financial toxicity related to the cost of cancer treatment in a diverse patient population. The research tests the feasibility of an application-based ("app") communication intervention designed to improve the frequency and quality of patient-oncologist treatment cost discussions during clinical interactions, which, in turn, should improve other short- and longer-term patient outcomes, including referrals to economic support (e.g., social work); efficacy in managing treatment cost; treatment cost distress; financial toxicity; and treatment adherence. If successful, this study will result in an evidence-based tool that can reduce financial toxicity and improve medical outcomes for a diverse patient population.

Eligibility criteria: Inclusion Criteria:

* Medical oncologists or radiation oncologists at KCI McLaren Detroit, McLaren Flint, McLaren Macomb and McLaren Port Huron oncology centers
* Oncologists will be eligible if they treat patients with prostate, breast, lung or colorectal cancers.
* Oncologists will be consented
* Patients must be 18 yrs. old or older
* Patients will be consented
* Patients must be able to read and write in English
* Patients must have a confirmed diagnosis of breast, prostate, lung or colorectal cancer and are scheduled to see an oncologist for an initial treatment discussion.

Exclusion Criteria:

* N/A

Primary outcomes:
measure: Patient-oncologist treatment cost discussions
timeFrame: During the treatment discussions and observed via video recordings of those discussions.
measure: Patient-oncologist treatment cost discussions
timeFrame: Collected immediately after the interaction with the oncologist
Secondary outcomes:
measure: Patient financial demographics
timeFrame: Collected immediately prior to the interaction with the oncologist
measure: Change in patient treatment cost information desired and gained
timeFrame: Collected immediately prior to and immediately after the interaction with the oncologist
measure: Change in patient efficacy in managing treatment cost (10-item scale). This measure will assess any change in the patients' efficacy in paying for the cost of their cancer treatment before and after the intervention.
timeFrame: Collected immediately prior to and immediately after the interaction with the oncologist
measure: Satisfaction with treatment cost discussions (3-item scale). This will assess the extent to which patients are satisfied with any discussions of treatment cost they had with their oncologist.
timeFrame: Collected immediately after the interaction with the oncologist
measure: Length of the interaction
timeFrame: During the patient-oncologist interaction and observed via video recordings of the treatment discussions
measure: DISCO App use (observer measure)
timeFrame: Prior to and during the patient-oncologist interaction
Other outcomes:
Locations:
city: Detroit
country: United States
facility: Barbara Ann Karmanos Cancer Institute
state: Michigan
Study officials:
affiliation: Barbara Ann Karmanos Cancer Institute
name: Lauren Hamel, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References: